Literature DB >> 2764981

Different binding of propranolol enantiomers to human alpha 1-acid glycoprotein.

J Oravcová1, S Bystricky, T Trnovec.   

Abstract

The binding of propranolol enantiomers to human alpha 1-acid glycoprotein was studied using high performance liquid chromatography in order to provide insight into binding models and to describe individual binding parameters of both enantiomers. The binding of (-)-propranolol was shown to be saturable with one major binding site (n = 0.81, k = 2.73 x 10(5)/M). The saturation process achieved its upper asymptotic value at drug/protein molar ratio of approximately 1. In the case of the opposite (+)-enantiomer the binding isotherm did not show evidence of saturation even at higher drug/protein molar ratios (up to 50). The individual binding parameters for (+)-enantiomer were n = 0.38, k = 3.4 x 10(6)/M and n'k' = 1.39 x 10(4)/M for the saturable and nonsaturable binding component, respectively. At drug/protein molar ratio 2 the circular dichroism measurements confirmed the existence of different binding models for individual propranolol enantiomers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2764981     DOI: 10.1016/0006-2952(89)90540-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

Review 2.  Enantioselective disposition of albuterol in humans.

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

3.  The influence of gender and sex steroid hormones on the plasma binding of propranolol enantiomers.

Authors:  U K Walle; T C Fagan; M J Topmiller; E C Conradi; T Walle
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.